Lutetium-labelled peptides for therapy of neuroendocrine tumours

por Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., Kwekkeboom, D. J.
Publicado 2012

Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

por van der Zwan, W. A., Brabander, T., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., Krenning, E. P., de Herder, W. W.
Publicado 2018

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

por Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., Erion, J. L., Krenning, E. P.
Publicado 2003